Canary Behavioral screens anxiety and depression via voice biomarkers from 20-second speech.
Competing Products
Canary Speech
Canary Speech: AI-driven vocal biomarkers for proactive health monitoring and disease simulation.
Founded
2016Canary Speech: AI-driven vocal biomarkers for proactive health monitoring and disease simulation.
Founded with the mission to revolutionize healthcare through AI-driven vocal biomarker technology, Canary Speech focuses on using conversational speech for virtual health monitoring. By analyzing just 20 seconds of speech, their patented technology models acoustic and linguistic features to detect stress, mood, and energy levels. This innovation aims to replace subjective health assessments with objective, actionable data, enhancing patient outcomes and enabling proactive health monitoring.
Notable figures affiliated with Canary Speech include experts in machine learning and healthcare technology. The company has attracted significant investment from leading venture capital firms specializing in health tech. Key achievements include securing patents for their vocal biomarker technology and establishing clinical-grade real-time vocal analysis. Canary Speech's impact is evident in its pioneering role in using voice as a vital sign, setting new standards in digital health diagnostics and patient care.
Companies similar to Canary Speech include Vocalis Health, Aural Analytics, Telling.ai and Ellipsis Health.
Canary Speech was founded in 2016.
Canary Speech's headquarters is located in Provo, UT, US.
Canary Speech's most recent funding round was for $1.9M (USD) in May 2023.
As of May 17, 2023, Canary Speech has disclosed funding of $5.3M (USD). Undisclosed round amounts are excluded.
Canary Speech has 37 employees as of Feb 5, 2024.
Ellipsis Health
ellipsishealth.com